Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases

Press/Media

Period	17 Dec 2018

Media coverage

Title	Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases
Media name/outlet	PharmiWeb
Country/Territory	United Kingdom
Date	17/12/18
URL	https://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=299378
Persons	Erwin Bottinger,